A California federal jury says Apple must pay Masimo $634M for infringing a blood-oxygen patent used in Watch workout and heart-rate alerts; Apple will appeal
A federal jury in California said on Friday that Apple (AAPL.O) owes medical-monitoring technology company Masimo (MASI.O) …
Context & Ripple Effects
The verdict is the latest turn in a dispute Masimo began in 2020, when it alleged Apple had appropriated technology related to blood-oxygen and heart-rate monitoring in an earlier patent lawsuit against Apple.
The companies have won narrow victories against each other: an ITC judge previously found some Apple Watches infringed a Masimo pulse-oximetry patent, while Apple later won only statutory-minimum damages over Masimo watch designs in a separate design-patent verdict.
First-order effects
- Apple faces a $634 million jury award and will move the dispute into appeal; Masimo gains a major damages judgment tied to Watch workout and heart-rate alerts.
- The ruling strengthens Masimo's position in this specific blood-oxygen patent fight, though the reported award is not final while Apple appeals.
Second-order effects
- The result gives both sides more leverage in their continuing IP conflict: Masimo can press its sensor-technology claims, while Apple can continue to rely on its separate design-patent win as a counterweight.
- Wearable-device makers using health-monitoring features may scrutinize patent exposure more closely, particularly where product alerts draw on specialized optical-sensing technology.
Third-order effects
- If courts continue to recognize enforceable sensor patents in consumer wearables, product differentiation in health features could depend more heavily on licensing, litigation resilience, and access to specialized medical-device IP.
- The Apple-Masimo fight illustrates a broader convergence of consumer electronics and medical monitoring, where contested technical ownership can shape feature rollouts as much as hardware design.
The trend: Consumer wearables are increasingly colliding with medical-device patent portfolios as health sensing becomes a core product capability.